Thursday, Abbott Laboratories ABT said it is recalling some FreeStyle Libre 3 sensors after finding that a small number of FreeStyle Libre 3 sensors may provide incorrect high glucose readings.

周四，雅培实验室ABT表示，在发现少量FreeStyle Libre 3传感器可能提供不正确的高糖读数后，正在召回一些FreeStyle Libre 3传感器。

The use of the affected product may cause serious adverse health consequences, including severe low blood sugar (hypoglycemia), which can cause central nervous system problems, loss of consciousness, seizures, coma, permanent brain damage, and death.

使用受影响的产品可能会导致严重的不良健康后果，包括严重的低血糖（低血糖），这可能导致中枢神经系统问题、意识丧失、癫痫发作、昏迷、永久性脑损伤和死亡。

There have been two reported injuries. There have been no reports of death.

据报道有两人受伤。目前还没有死亡报告。

Also Read: Dexcom’s Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients.

另请阅读：Dexcom的Stelo设备为2型糖尿病患者带来了负担得起的连续血糖监测。

This recall involves removing certain devices from where they are used or sold and does not apply to the FreeStyle Libre 3 reader or app.

此次召回涉及从使用或销售的地方删除某些设备，不适用于FreeStyle Libre 3阅读器或应用程序。

The FreeStyle Libre 3 Continuous Glucose Monitoring System is intended to monitor glucose levels continuously. It helps people manage diabetes by detecting trends and tracking patterns in glucose levels so treatment can be adjusted as needed. It is indicated for single-patient use and requires a prescription..

FreeStyle Libre 3连续血糖监测系统旨在连续监测血糖水平。。它适用于单一患者使用，需要处方。。

In July, Abbott sent all affected customers an Urgent Medical Device Recall recommending discontinuing the use, disposing of any affected sensors, and requesting a replacement.

。

Concurrently, on Thursday, Abbott announced the U.S. availability of Lingo, the company’s first continuous glucose monitoring system, without a prescription.

与此同时，周四，雅培宣布在美国推出Lingo，这是该公司第一款无需处方的连续血糖监测系统。

The Lingo system includes a biosensor and a mobile app designed for consumers who want to improve their overall health and wellness.

Lingo系统包括一个生物传感器和一个移动应用程序，专为想要改善整体健康状况的消费者设计。

Lingo is based on Abbott’s FreeStyle Libre continuous glucose monitoring technology.

Lingo基于雅培的FreeStyle Libre连续血糖监测技术。

Abbott’s consumer biowearable, Lingo, is available for consumers 18 years and older not on insulin. Lingo tracks glucose in real-time and provides personal insights and coaching to help people build healthy habits, retrain their metabolism, and improve their overall well-being.

雅培（Abbott）的消费者生物穿戴设备Lingo适用于18岁及以上的消费者，不使用胰岛素。Lingo实时跟踪血糖，并提供个人见解和指导，以帮助人们建立健康的习惯，重新训练新陈代谢，改善整体幸福感。

Price Action: ABT stock is down 0.82% at $113.46 at last check Thursday.

价格走势：周四最后一次检查显示，ABT股价下跌0.82%，至113.46美元。

Read Next:

阅读下一页：

Battle Over Compounded Weight-Loss Medications – Sustainability and Regulation.

对抗复合减肥药物-可持续性和监管。

Photo via ShutterstockMarket News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

照片通过ShutterstockMarket News和Benzinga API提供给您的数据©2024 Benzinga.com。Benzinga不提供投资建议。保留所有权利。